(Q54383300)

29 May 2018

title

Why does atorvastatin inhibit renal crystal retention? (English)

1 reference

29 May 2018

author name string

Masao Tsujihata

1

1 reference

29 May 2018

Iwao Yoshioka

2

1 reference

29 May 2018

Akira Tsujimura

3

1 reference

29 May 2018

Norio Nonomura

4

1 reference

29 May 2018

Akihiko Okuyama

5

1 reference

29 May 2018

publication date

12 March 2011

1 reference

29 May 2018

published in

Urological Research

1 reference

29 May 2018

volume

39

1 reference

29 May 2018

issue

5

1 reference

29 May 2018

page(s)

379-383

1 reference

29 May 2018

Prospective Study on the Efficacy of a Selective Treatment and Risk Factors for Relapse in Recurrent Calcium Oxalate Stone Patients

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00240-011-0370-1

Hyperoxaluria-induced oxidative stress and antioxidants for renal protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00240-011-0370-1

Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00240-011-0370-1

Cellular antioxidant effects of atorvastatin in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00240-011-0370-1

Atorvastatin inhibits renal crystal retention in a rat stone forming model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00240-011-0370-1

Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of a tetracyclic catechol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00240-011-0370-1

Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00240-011-0370-1

Automated assays for superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00240-011-0370-1

NAD(P)H oxidase: role in cardiovascular biology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00240-011-0370-1

Cell transformation by the superoxide-generating oxidase Mox1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00240-011-0370-1

Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00240-011-0370-1

Atorvastatin ameliorates renal tissue damage in unilateral ureteral obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00240-011-0370-1

Free radicals and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00240-011-0370-1

Effect of angiotensin II receptor blockage on osteopontin expression and calcium oxalate crystal deposition in rat kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00240-011-0370-1

Superoxide from NADPH oxidase as second messenger for the expression of osteopontin and monocyte chemoattractant protein-1 in renal epithelial cells exposed to calcium oxalate crystals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00240-011-0370-1

Adhesion of calcium oxalate crystals to Madin-Darby canine kidney cells and some effects of glycosaminoglycans or cell injuries

21 January 2018

1 reference

12 December 2020

Protective role of enalapril for chronic tubulointerstitial lesions of hyperoxaluria

1 reference

12 December 2020

Effects of angiotensin II subtype 1 receptor blockade by losartan on tubulointerstitial lesions caused by hyperoxaluria

1 reference

12 December 2020

Lovastatin inhibits transforming growth factor-beta1 expression in diabetic rat glomeruli and cultured rat mesangial cells

1 reference

12 December 2020

NADPH oxidase: an update

1 reference

12 December 2020

Angiotensin II: a regulator of inflammation during renal disease?

1 reference

12 December 2020

Angiotensin type-1 receptor blocker candesartan inhibits calcium oxalate crystal deposition in ethylene glycol-treated rat kidneys

1 reference

12 December 2020

Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia

1 reference

12 December 2020

10.1007/S00240-011-0370-1

Identifiers

DOI

1 reference

29 May 2018

1 reference

29 May 2018